查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442833

过敏免疫治疗市场[治疗：皮下免疫疗法 (SCIT) 和舌下免疫疗法 (SLIT)]-2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Allergy Immunotherapy Market [Treatment: Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)]- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 222 Pages | 商品交期: 2-10个工作天内

价格

过敏免疫治疗市场 - 报告范围

TMR 关于全球过敏免疫治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球过敏免疫治疗市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球过敏免疫治疗市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解过敏免疫治疗市场。

该报告深入探讨了全球过敏免疫疗法市场的竞争格局。全球过敏免疫治疗市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球过敏免疫治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测
  • 波特五力分析

第 5 章：关键见解

  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按处理方式

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依处理方式，2017-2031
    • 皮下免疫疗法（SCIT）
    • 舌下免疫疗法（SLIT）
  • 市场吸引力分析：按处理方式

第 7 章：全球市场分析与预测：按过敏类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依过敏类型，2017-2031
    • 过敏性鼻炎
    • 气喘
    • 食物过敏
    • 毒液过敏
    • 其他的
  • 市场吸引力分析：按过敏类型

第 8 章：全球市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2017-2031
    • 医院药房
    • 零售药局和药局
    • 网路药局
  • 市场吸引力分析：按配销通路

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2021 年）
  • 公司简介
    • ALK-Abello A/S
    • Allergy Therapeutics
    • Stallergenes Greer
    • HAL Allergy Group
    • DBV Technologies
    • Merck KGaA
    • Aimmune Therapeutics
    • Carcassia
    • Anergis
    • Biomay AG
Product Code: TMRGL35708

Allergy Immunotherapy Market - Scope of Report

TMR's report on the global allergy immunotherapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global allergy immunotherapy market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global allergy immunotherapy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the allergy immunotherapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global allergy immunotherapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global allergy immunotherapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global allergy immunotherapy market.

The report delves into the competitive landscape of the global allergy immunotherapy market. Key players operating in the global allergy immunotherapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global allergy immunotherapy market profiled in this report.

Key Questions Answered in Global allergy immunotherapy Market Report:

  • What is the sales/revenue generated by allergy immunotherapy across all regions during the forecast period?
  • What are the opportunities in the global allergy immunotherapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Allergy Immunotherapy Market - Research Objectives and Research Approach

The comprehensive report on the global allergy immunotherapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global allergy immunotherapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global allergy immunotherapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy Immunotherapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Allergy Immunotherapy Market Analysis and Forecast, 2017-2031
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. COVID-19 Pandemic Impact on Industry

6. Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Treatment, 2017-2031
    • 6.3.1. Subcutaneous Immunotherapy (SCIT)
    • 6.3.2. Sublingual Immunotherapy (SLIT)
  • 6.4. Market Attractiveness Analysis, by Treatment

7. Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Allergy Type, 2017-2031
    • 7.3.1. Allergic Rhinitis
    • 7.3.2. Asthma
    • 7.3.3. Food Allergy
    • 7.3.4. Venom Allergy
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, By Allergy Type

8. Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies & Drug Stores
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, By Distribution Channel

9. Global Allergy Immunotherapy Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Allergy Immunotherapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Treatment, 2017-2031
    • 10.2.1. Subcutaneous Immunotherapy (SCIT)
    • 10.2.2. Sublingual Immunotherapy (SLIT)
  • 10.3. Market Value Forecast, by Allergy Type, 2017-2031
    • 10.3.1. Allergic Rhinitis
    • 10.3.2. Asthma
    • 10.3.3. Food Allergy
    • 10.3.4. Venom Allergy
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies & Drug Stores
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Treatment
    • 10.6.2. By Allergy Type
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Allergy Immunotherapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment, 2017-2031
    • 11.2.1. Subcutaneous Immunotherapy (SCIT)
    • 11.2.2. Sublingual Immunotherapy (SLIT)
  • 11.3. Market Value Forecast, by Allergy Type, 2017-2031
    • 11.3.1. Allergic Rhinitis
    • 11.3.2. Asthma
    • 11.3.3. Food Allergy
    • 11.3.4. Venom Allergy
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies & Drug Stores
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Treatment
    • 11.6.2. By Allergy Type
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment, 2017-2031
    • 12.2.1. Subcutaneous Immunotherapy (SCIT)
    • 12.2.2. Sublingual Immunotherapy (SLIT)
  • 12.3. Market Value Forecast, by Allergy Type, 2017-2031
    • 12.3.1. Allergic Rhinitis
    • 12.3.2. Asthma
    • 12.3.3. Food Allergy
    • 12.3.4. Venom Allergy
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies & Drug Stores
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Treatment
    • 12.6.2. By Allergy Type
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Allergy Immunotherapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment, 2017-2031
    • 13.2.1. Subcutaneous Immunotherapy (SCIT)
    • 13.2.2. Sublingual Immunotherapy (SLIT)
  • 13.3. Market Value Forecast, by Allergy Type, 2017-2031
    • 13.3.1. Allergic Rhinitis
    • 13.3.2. Asthma
    • 13.3.3. Food Allergy
    • 13.3.4. Venom Allergy
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies & Drug Stores
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Treatment
    • 13.6.2. By Allergy Type
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Treatment, 2017-2031
    • 14.2.1. Subcutaneous Immunotherapy (SCIT)
    • 14.2.2. Sublingual Immunotherapy (SLIT)
  • 14.3. Market Value Forecast, by Allergy Type, 2017-2031
    • 14.3.1. Allergic Rhinitis
    • 14.3.2. Asthma
    • 14.3.3. Food Allergy
    • 14.3.4. Venom Allergy
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies & Drug Stores
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Treatment
    • 14.6.2. By Allergy Type

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. ALK-Abello A/S
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Treatment Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Allergy Therapeutics
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Treatment Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Stallergenes Greer
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Treatment Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. HAL Allergy Group
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Treatment Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. DBV Technologies
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Treatment Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Merck KGaA
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Treatment Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Aimmune Therapeutics
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Treatment Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Carcassia
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Treatment Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Anergis
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Treatment Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Biomay AG
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Treatment Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Figures

  • Figure 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Allergy Immunotherapy Market Value Share, by Treatment, 2022
  • Figure 03: Global Allergy Immunotherapy Market Value Share, by Distribution Channel, 2022
  • Figure 04: Global Allergy Immunotherapy Market Value Share, by Region, 2022
  • Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 06: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Silicone, 2017-2031
  • Figure 08: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Polyolefins, 2017-2031
  • Figure 9: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
  • Figure 10: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
  • Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Allergic Rhinitis, 2017-2031
  • Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn), Asthma, 2017-2031
  • Figure 13: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Food Allergy, 2017-2031
  • Figure 14: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Venom Allergy, 2017-2031
  • Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 16: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 17: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Retail Pharmacies & Drug Stores, 2017-2031
  • Figure 20: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 23: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 25: North America Allergy Immunotherapy Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
  • Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
  • Figure 30: North America Allergy Immunotherapy Market Value Share Analysis (US$ Mn), by Distribution Channel, 2017-2031
  • Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 32: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 33: Europe Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 34: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 36: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 37: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
  • Figure 38: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
  • Figure 39: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 40: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 41: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 43: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
  • Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
  • Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 50: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 51: Latin America Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 52: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 53: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 54: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 55: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017-2031
  • Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
  • Figure 54: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 56: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 57: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 59: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 60: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 61: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017-2031
  • Figure 62: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
  • Figure 63: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 64: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031

List of Tables

  • Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
  • Table 02: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 07: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
  • Table 08: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 11: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 12: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
  • Table 13: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 15: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
  • Table 16: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 19: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
  • Table 20: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 23: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
  • Table 24: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031